TMCnet News

Research and Markets: EpiCast Report: Growth Hormone Deficiency Study 2015 - Epidemiology Forecast to 2024
[November 27, 2015]

Research and Markets: EpiCast Report: Growth Hormone Deficiency Study 2015 - Epidemiology Forecast to 2024


Research and Markets (http://www.researchandmarkets.com/research/3899kd/epicast_report) has announced the addition of the "EpiCast Report: Growth Hormone Deficiency - Epidemiology Forecast to 2024" report to their offering.

Growth hormone deficiency (GHD) is an endocrine disorder characterized by low or deficient secretion of growth hormone (GH) secondary to malfunction of the pituitary gland, a pea-sized structure located at the base of the brain that is responsible for the production of GH. The International Classification of Diseases (ICD-10) ICD-10-CM code for GHD is E23.0.

GHD in children can be classified as idiopathic or organic, which is further divided into congenital and acquired. GH is necessary for normal growth, as it fuels childhood growth and development.In an adult's normal lifespan, GH is needed to maintain the amounts of body fat, muscle, and bone necessary for sustaining tissue and organ function. GHD acquired in adulthood is usually acquired through damage to the pituitary-hypothalamic region through trauma or tumors. This report does not cover childhood-onset GHD that progresses into adulthood.



In the 7MM, the diagnosed prevalent cases of GHD for all ages and both sexes will increase from 97,985 cases in 2014 to 100,494 cases in 2024, at an Annual Growth Rate (AGR) of 0.26%. The publisher epidemiologists forecast a small increase in the AGR of the diagnosed prevalent cases of GHD from 2014-2024 for all included markets except for Germany and Japan. The majority of diagnosed prevalent cases of GHD in children in the 7MM are in boys. In the 7MM, 68.05% of the GHD cases in children are in boys and the trend is consistent in the individual markets. In adults, the distribution is also skewed towards men in the US and the 5EU.

Key Topics Covered:


1 Tables & Figures

2 Introduction

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global Trends

3.4 Forecast Methodology

3.5 Epidemiological Forecast of GHD (2014-2024)

3.6 Discussion

4 Appendix

For more information visit http://www.researchandmarkets.com/research/3899kd/epicast_report


[ Back To TMCnet.com's Homepage ]